8-K Announcements
6Material company update
Jun 4, 2026·SEC
Material company update
May 20, 2026·SEC
Material company update
May 6, 2026·SEC
Aimei Health Technology Co., Ltd(AFJK)Earnings, Financials & Key Ratios
AFJK•NASDAQ•Banking & Credit
$26.69
157.0× P/E·Price updated Jul 7, 2026
SectorFinancial ServicesIndustrySPACs & Shell CompaniesSub-IndustryHealthcare and life sciences SPACs
AboutAimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.Show more
- Net Interest Income$2M-47.6%
- Total Revenue$0
- Net Income$1M-58.5%
- Return on Equity2.64%-26.6%
- Net Interest Margin15.66%+219.6%
- ROA2.47%-30.3%
- Equity / Assets66.44%-32.2%
- Book Value per Share1.99-75.2%
AFJK Price & Volume
Aimei Health Technology Co., Ltd (AFJK) stock price & volume — 10-year historical chart
Loading chart...
Rapid Asset Dissipation Threatens Shell Entity Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Immediate going concern liquidity
Key Thesis Takeaways
- Aimei Health Technology Co., Ltd.
- currently functions as a passive shell entity characterized by a severe contraction in its asset base and a lack of active business combination progress.
- The firm's reliance on liquidating investment securities to cover operational overhead, combined with a dwindling cash position, suggests significant going-concern risks.
- Investors should monitor the company's ability to secure external capital, as the current trajectory of capital depletion appears unsustainable for long-term listing maintenance.
Verdict Logic
the firm's current P/B ratio of 13.49 appears disconnected from its deteriorating financial health and the near-total depletion of its liquid asset base.
AFJK Growth Metrics
Aimei Health Technology Co., Ltd (AFJK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-53.54%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-23.68%
Return on Capital
10 Years-1.19%
5 Years-1.19%
3 Years-1.19%
Last Year-2.05%
AFJK Recent Earnings
Aimei Health Technology Co., Ltd (AFJK) EPS & revenue vs analyst estimates — last 4 quarters
Q3 2026Latest
Jun 16, 2026Metric
Actual
Est
EPS
$0.01
—
Rev
—
—
Q2 2026
May 4, 2026Metric
Actual
Est
EPS
$0.02
—
Rev
—
—
Q2 2026
Apr 3, 2026Metric
Actual
Est
EPS
$0.05
—
Rev
—
—
Q4 2025
Nov 18, 2025Metric
Actual
Est
EPS
$0.06
—
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 16, 2026 | $0.01 | — |
| Q2 2026 | May 4, 2026 | $0.02 | — |
| Q2 2026 | Apr 3, 2026 | $0.05 | — |
| Q4 2025 | Nov 18, 2025 | $0.06 | — |
Based on last 11 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Aimei Health Technology Co., Ltd (AFJK)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $26.69 | $163.39M | 157.00 | — | — | 2.64% | — | |
| $0.23 | $88.51M | -0.14 | 498.08% | -91.96% | -60.5% | — | |
| $1.65 | $537.3M | -5.32 | -30.65% | -146.01% | -0.11% | — | |
| $5.00 | $2.59B | -29.41 | 40.34% | -2.58% | -17.08% | — | |
| $94.66 | $6.27B | 69.09 | 15.24% | 9.48% | 5.13% | — | |
| $3.03 | $1.05B | 35.52 | 0.57% | 3.74% | 4.75% | — |
Compare AFJK vs Peers
Aimei Health Technology Co., Ltd (AFJK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AFJK SEC Filings & Documents
Aimei Health Technology Co., Ltd (AFJK) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when AFJK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AFJK Frequently Asked Questions
Aimei Health Technology Co., Ltd (AFJK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Is AFJK profitable?
Yes, Aimei Health Technology Co., Ltd (AFJK) is profitable, generating $0.9M in net income for fiscal year 2025.
Dividend & Returns
What is AFJK's return on equity?
Aimei Health Technology Co., Ltd (AFJK) has a return on equity (ROE) of 2.6%. This is below average, suggesting room for improvement.
Industry Metrics
What is Aimei Health Technology Co., Ltd's net interest margin?
Aimei Health Technology Co., Ltd (AFJK) has a net interest margin (NIM) of 15.7%. This indicates healthy earnings from lending activities.